• Médecine

Clinical Research Group on Inflammatory Amyloidosis (AA) Sorbonne University


  • Clinical Research Groups

AA amyloidosis is a rare heterogeneous disease related to the deposition in tissues of an inflammation protein: Serum Amyloid A protein (SAA). It complicates chronic inflammatory states and has a significant morbidity/mortality. Our research group will be a unique structure composed of all the clinical and medico-technical services involved in the management of AA amyloidosis at Sorbonne University. Its objectives are to create an epidemiological database, to develop more efficient diagnostic and monitoring tools, to better understand the pathophysiology and to set up therapeutic trials. Already supported by the French Amyloidosis Patient Association, it aims to be the national and European leader on AA amyloidosis by the number of patients included and the synergy of all specialists involved.


Pr Sophie Georgin-Lavialle, internist
Pr David Buob, pathologist
Pr Jean-Jacques Boffa, nephrologist
Pr Valérie Martinez, infectious disease specialist
Pr Harry Sokol, gastroenterologist
Pr Gilles Grateau, internist


  • Sophie Georgin Lavialle

Co leader of the project

  • David Buob


Adresse physique

Hôpital Tenon, 4 rue de Chine
75020 Paris
Hopital Tenon
Hopital Tenon